Search Results - "Livingston, John A"

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers by Amin, Hesham M, Morani, Ajaykumar C, Daw, Najat C, Lamhamedi-Cherradi, Salah-Eddine, Subbiah, Vivek, Menegaz, Brian A, Vishwamitra, Deeksha, Eskandari, Ghazaleh, George, Bhawana, Benjamin, Robert S, Patel, Shreyaskumar, Song, Juhee, Lazar, Alexander J, Wang, Wei-Lien, Kurzrock, Razelle, Pappo, Alberto, Anderson, Peter M, Schwartz, Gary K, Araujo, Dejka, Cuglievan, Branko, Ratan, Ravin, McCall, David, Mohiuddin, Sana, Livingston, John A, Molina, Eric R, Naing, Aung, Ludwig, Joseph A

“…: Ten to fourteen percent of Ewing sarcoma (ES) study participants treated nationwide with IGF-1 receptor (IGF-1R)-targeted antibodies achieved tumor…”
Get full text

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy by Miller, Devon, Livingston, John A., Park, Yeonhee, Posey, Kristi, Godbole, Sonia, Skubitz, Keith, Robinson, Steven I., Agulnik, Mark, Davis, Lara E., Van Tine, Brian A., Hirbe, Angela C., Parkes, Amanda

“…Background Sarcomas are rare diagnoses but are seen with relative frequency in adolescents and young adults and thus can present in pregnancy. We sought to…”
Get full text

Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma by Thirasastr, Prapassorn, Lin, Heather, Amini, Behrang, Wang, Wei‐Lien, Cloutier, Jeffrey M., Nassif, Elise F., Keung, Emily Z., Roland, Christina L., Feig, Barry, Araujo, Dejka, Benjamin, Robert S., Conley, Anthony P., Livingston, John A., Ludwig, Joseph, Patel, Shreyaskumar, Ratan, Ravin, Ravi, Vinod, Zarzour, Maria Alejandra, Zhou, Xiao, Somaiah, Neeta

“…Objective Well‐differentiated (WDLPS) and dedifferentiated liposarcoma (DDLPS) account for the majority of liposarcomas. Although gemcitabine‐docetaxel is used…”
Get full text

Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma by Boyce‐Fappiano, David, Guadagnolo, B. Ashleigh, Ratan, Ravin, Wang, Wei‐Lien, Wagner, Michael J., Patel, Shreyaskumar, Livingston, John A., Lin, Patrick P., Diao, Kevin, Mitra, Devarati, Farooqi, Ahsan, Lazar, Alexander J., Roland, Christina L., Bishop, Andrew J.

“…Objectives We reviewed our experience treating patients with localized extraskeletal Ewing sarcoma (EES) to determine optimal local management strategies for…”
Get full text

Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma by Lamhamedi-Cherradi, Salah-Eddine, Mohiuddin, Sana, Mishra, Dhruva K., Krishnan, Sandhya, Velasco, Alejandra Ruiz, Vetter, Amelia M., Pence, Kristi, McCall, David, Truong, Danh D., Cuglievan, Branko, Menegaz, Brian A., Utama, Budi, Daw, Najat C., Molina, Eric R., Zielinski, Rafal J., Livingston, John A., Gorlick, Richard, Mikos, Antonios G., Kim, Min P., Ludwig, Joseph A.

“…Osteosarcoma (OS) is a molecularly heterogeneous, aggressive, poorly differentiated pediatric bone cancer that frequently spreads to the lung. Relatively…”
Get full text

Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology by El Beaino, Marc, Roszik, Jason, Livingston, John A., Wang, Wei-Lien, Lazar, Alexander J., Amini, Behrang, Subbiah, Vivek, Lewis, Valerae, Conley, Anthony P.

“…Mesenchymal chondrosarcoma is a rare but deadly form of chondrosarcoma that typically affects adolescents and young adults. While curative intent is possible…”
Get full text

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma by Roszik, Jason, Mustachio, Lisa Maria, Livingston, John A., Groisberg, Roman, Carmagnani Pestana, Roberto, Subbiah, Vivek, Conley, Anthony P.

“…Soft tissue sarcomas, depending on the subtype and grade, frequently recur and become metastatic after localized treatment. There is now great interest in…”
Get full text

Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter? by Thirasastr, Prapassorn, Sutton, Thomas L, Joseph, Cissimol P, Lin, Heather, Amini, Behrang, Mayo, Skye C, Araujo, Dejka, Benjamin, Robert S, Conley, Anthony P, Livingston, John A, Ludwig, Joseph, Patel, Shreyaskumar, Ratan, Ravin, Ravi, Vinod, Zarzour, Maria A, Nassif Haddad, Elise F, Nakazawa, Michael S, Zhou, Xiao, Heinrich, Michael C, Somaiah, Neeta

“…Ripretinib and avapritinib have demonstrated activity in the late-line treatment of gastrointestinal stomal tumors (GISTs). We investigated whether patients…”
Get full text

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes by Roszik, Jason, Wang, Wei-Lien, Livingston, John A, Roland, Christina L, Ravi, Vinod, Yee, Cassian, Hwu, Patrick, Futreal, Andrew, Lazar, Alexander J, Patel, Shreyaskumar R, Conley, Anthony P

“…PRAME (preferentially expressed antigen in melanoma), a member of the cancer-testis antigen family, has been shown to have increased expression in solid…”
Get full text

Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control by Bishop, Andrew J, Bird, Justin E, Conley, Anthony P, Roland, Christina L, Moon, Bryan S, Satcher, Robert L, Livingston, John A, Patel, Shreyaskumar, Wang, Wei-Lien, Lazar, Alexander J, Lewis, Valerae O, Lin, Patrick P, Guadagnolo, B Ashleigh

“…We evaluated our experience treating patients with localized extraskeletal myxoid chondrosarcomas (EMCs) to evaluate outcomes and relapse rates in order to…”
Get full text

MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma by Conley, Anthony P, Wang, Wei-Lien, Livingston, John A, Ravi, Vinod, Tsai, Jen-Wei, Ali, Ali, Ingram, Davis R, Lowery, Caitlin D, Roland, Christina L, Somaiah, Neeta, Hwu, Patrick, Yee, Cassian, Subbiah, Vivek, Futreal, Andrew, Lazar, Alexander J, Patel, Shreyaskumar, Roszik, Jason

“…Melanoma-associated antigen 3 (MAGE-A3) expression is generally restricted to the placenta and germline cells of the testis, but it may also be expressed in…”
Get full text

Emergency Department Visits by Adolescent and Young Adult Cancer Patients Compared with Pediatric Cancer Patients in the United States by Kaul, Sapna, Russell, Heidi, Livingston, John A, Kirchhoff, Anne C, Jupiter, Daniel

“…Limited information exists on emergency department (ED) visits for adolescent and young adult (AYA) patients with cancer. We examined the clinical reasons for…”
Get more information

Abstract 1291: Notch2 inhibition as a therapeutic intervention in osteosarcoma by Kannan, Sankaranarayanan, Livingston, John A., Roth, Michael, Benjamin, Jonathan, Wang, Yifei, Zhang, Zhongting, Zhang, Wendong, Wu, Chia-Chin, Beird, Hannah, Futreal, Andrew, Gorlick, Richard

“…Notch signaling pathway is a mediator of cell differentiation and is critical for normal bone development. Four functional Notch ligands DLL1 and DLL4, and…”
Get full text

Abstract 518: Immunogenomic correlates of response to combination immune checkpoint blockade in advanced sarcoma by Mitra, Akash, Somaiah, Neeta, Conley, Anthony P., Amini, Behrang, Lin, Heather, Sanchez, Beatriz E., Garcia-Prieto, Celia, Mathew, Grace, Bernatchez, Chantale, Ravi, Vinod, Araujo, Dejka, Zarzour, Maria A., Livingston, John A., Roland, Christina L., Daw, Najat, Baguley, Joshua, Wang, Wei-Lien, Beird, Hannah, Tate, Taylor, Haymaker, Cara, Little, Latasha D., Gumbs, Curtis, Song, Xingshi, Keung, Emily Z., Zhang, Shaojun, Gite, Swati, Zhang, Jianhua, Solis, Luisa, Tawbi, Hussein, Wang, Linghua, Patel, Shreyaskumar, Benjamin, Robert S., Lazar, Alexander J., Wistuba, Ignacio I., Futreal, Andrew

“…Sarcomas encompass a rare but highly diverse set of tumor malignancies, contributing disproportionately to years of life lost. Immune checkpoint blockade (ICB)…”
Get full text

Abstract 1997: Health-related quality of life at diagnosis in survivors of adolescent and young adult cancer by George, Goldy C., Andersen, Clark R., Tang, Xiaohui, Livingston, John A., Roth, Michael E., Hildebrandt, Michelle A.

“…Purpose: Data are lacking on the distribution, factors associated with, and long-term impact of diminished health-related quality of life (HRQoL) at diagnosis…”
Get full text

Abstract 7548: Role of bromodomain extra terminal inhibitor (BETi) in combination with radiotherapy for the treatment of NF1-associated malignant peripheral nerve sheath tumor by Gingrich, Alcia A., Landers, Sharon, Bhalla, Angela, Rodriguez-Aguayo, Cristian, Lazcano, Rossana, Satpati, Suresh, Lebron-Torres, Alines, Keung, Emily Z., Scally, Christopher P., Roland, Christina L., Hunt, Kelly K., Lyu, Heather, Lillemoe, Heather, Guadagnolo, Ashleigh, Lazar, Alexander, Slopis, John, McCutcheon, Ian, Livingston, John A., Farooqi, Ahsan, Rai, Kunal, Torres, Keila E.

“…Introduction: Neurofibromatosis Type 1 (NF-1) associated malignant peripheral nerve sheath tumors (MPNST) harbor mutations in the polycomb repressive complex 2…”
Get full text

Moral Concern and the Ecosphere by Livingston, John A.

Get full text

The Fallacy of Wildlife Conservation by Fox, Irving K.

Get full text

Birds of the Northern Forest by Weeden, Robert B.

Get full text